Price-to-Sales Ratio | Purchaser | Acquired | Purchase Price (M) | Acquired Company's Annual Sales (M) |
---|---|---|---|---|
22.5 | Yourgene Health | Coastal Genomics | $ 14 | $ 0.6 |
14.2 | Sartorius | BIA Separations | $ 412 | $ 29 |
7.6 | Integument | Modern Waters | $ 28 | $ 4 |
6.7 | Repligen | ArteSYN Biosolutions | $ 200 | $ 30 |
5.1 | PerkinElmer | Horizon Discovery | $ 383 | $ 76 |
4.9 | Sartorius | Various Danaher Businesses | $ 825 | $ 170 |
Amount Paid (M) | Purchaser | Acquired | Sales (M) |
---|---|---|---|
$ 1,700 | Amphenol | MTS Systems | $ 893 |
$ 1,065 | Royal DSM | Erber | $ 367 |
$ 825 | Sartorius | Various Danaher Businesses | $ 170 |
$ 412 | Sartorius | BIA Separations | $ 29 |
$ 383 | PerkinElmer | Horizon Discovery | $ 76 |
$ 350 | 10x Genomics | ReadCoor | NA |
Company | Number |
---|---|
Bruker | 3 |
Calibre Scientific | 3 |
Gamma Biosciences | 3 |
PerkinElmer* | 3 |
10x Genomics | 2 |
Abcam | 2 |
Ashai Glassplant | 2 |
Danaher | 2 |
Illumina | 2 |
Repligen | 2 |
Sartorius | 2 |
Rev. (M) |
Chg. | |
---|---|---|
Total Company |
SEK 262.6 |
-7.1% |
Systems |
SEK 237.3 |
-7.7% |
Service Contracts and Other Services |
SEK 23.6 |
0.1% |
Other Sales Revenue |
SEK 1.7 |
-18.1% |
Op. Profit (M) |
Chg. |
Op. Margin |
Chg. (bps) |
---|---|---|---|
SEK 60.7 |
-5.6% |
23.1% |
37 |
Rev. (M) |
Chg. |
% of Rev. | |
---|---|---|---|
Americas |
SEK 111.8 |
-12.9% |
43% |
Europe & EMEA |
SEK 69.6 |
5.9% |
26% |
Asia |
SEK 81.2 |
-8.3% |
31% |
Rev. (M) |
Chg. | |
---|---|---|
Organic Chemistry |
SEK 141.8 |
7.1% |
Analytical Chemistry |
SEK 86.2 |
-8.4% |
Scale-Up (formerly Industrial Products) |
SEK 25.5 |
-46.3% |
Biomolecules |
SEK 9.1 |
4.5% |
Rev. (M) |
Chg. |
% of Rev. | |
---|---|---|---|
Direct Sales |
SEK 245.3 |
-8.9% |
93.4% |
Distributors |
SEK 17.2 |
28.5% |
6.6% |
Rev. (M) |
Chg. |
Acq./Div. |
Currency |
Organic Chg. |
% of Rev. | |
---|---|---|---|---|---|---|
Total |
$204.2 |
11.4% |
0% |
1% |
10% |
|
Protein Sciences |
$154.4 |
9.5% |
0% |
2% |
8% |
76% |
Diagnostics and Genomics |
$50.1 |
17.8% |
0% |
1% |
17% |
25% |
Intersegment |
-$0.4 |
22.4% |
— |
— |
— |
— |
Adj. Op. Margin |
Chg. (bps) | |
---|---|---|
Total |
38.7% |
576 |
Protein Sciences |
45.6% |
332 |
Diagnostics and Genomics |
17.5% |
1537 |
Rev. |
Chg. |
% of Rev. | |
---|---|---|---|
US |
$113.6 |
11.0% |
56% |
EMEA, excl. UK |
$43.1 |
11.2% |
21% |
UK |
$8.5 |
12.5% |
4% |
APAC, excl. Greater China |
$15.7 |
12.3% |
8% |
Greater China |
$18.1 |
12.3% |
9% |
Rest of World |
$5.2 |
17.5% |
3% |
Rev. (M) |
Chg. |
% of Rev. | |
---|---|---|---|
Process & Environmental Instruments & Systems |
¥4,125 |
-12.4% |
9% |
Scientific Instruments & Systems |
¥6,965 |
13.6% |
15% |
SI |
PE | |||
---|---|---|---|---|
|
Rev. (M) |
Chg. |
Rev. (M) |
Chg. |
Japan |
¥1,202 |
-22.3% |
¥2,143 |
-13.1% |
Asia |
¥2,124 |
29.0% |
¥921 |
-1.2% |
Americas |
¥2,132 |
18.1% |
¥548 |
-17.5% |
Europe |
¥1,507 |
32.9% |
¥514 |
-20.7% |
Rev. (B) |
% Chg. |
Local Currency Chg. | |
---|---|---|---|
Total |
¥62.1 |
-2.6% |
-4.0% |
Key Models |
¥34.8 |
5.2% |
2.0% |
Other |
¥27.3 |
-11.0% |
- |
Op. Profit |
Chg. |
Local Currency Chg. |
Op. Margin |
Chg. (bps) |
---|---|---|---|---|
¥11.8 |
10.0% |
7.0% |
19.0% |
218 |
Chg. |
Local Currency Chg. |
% of Rev. | |
---|---|---|---|
Japan |
-13.1% |
-15.0% |
40% |
Americas |
6.8% |
- |
12% |
North America |
10.8% |
13.0% |
- |
South America |
-22.4% |
- |
- |
Europe |
-3.4% |
-5.0% |
10% |
China |
15.3% |
14.0% |
23% |
Other Asia |
-1.2% |
-9.0% |
11% |
India |
15.9% |
-4.0% |
- |
Other |
0.4% |
- |
2% |
Chg. |
Local Currency Chg. |
% of Rev. | |
---|---|---|---|
Japan |
1.0% |
-11.0% |
36% |
Americas |
-14.2% |
- |
12% |
North America |
-6.8% |
-4.0% |
- |
South America |
-55.6% |
- |
- |
Europe |
-9.1% |
-5.0% |
10% |
China |
9.8% |
12.0% |
29% |
Other Asia |
-23.6% |
-25.0% |
11% |
India |
-29.9% |
-35.0% |
- |
Other |
-26.2% |
- |
2% |
# of Facilities | Number of Cleanrooms | Total Cleanroom Space (m2) | Chg. in Cleanroom Space | In-hose QC Space (m2) | Full-time Employees | Avg. Booked Capacity | |
---|---|---|---|---|---|---|---|
Cell Therapy | 11 | 56 | 1,517 | 8.0% | 483 | 154 | 86% |
Gene Therapy | 8 | 57 | 6,694 | 72.1% | 7,849 | 603 | 95% |
Multifunctional | 7 | NA | 3,545 | 32.5% | 850 | 553 | 75% |
| Change | Euros (M) | US Dollars (M) |
---|---|---|---|
Center for the Development of Industrial Technology (CDTI) | -0.5% | € 1,504.9 | $1,770.47 |
Higher Council for Scientific Research (CSIC) | 43.8% | € 906.2 | $1,066.12 |
State Research Agency (AEI) | 29.0% | € 825.7 | $971.41 |
Carlos III Health Institute (ISCIII) | 48.4% | € 402.7 | $473.76 |
Center for Energy, Environmental and Technological Research (CIEMAT) | 44.8% | € 128.3 | $150.94 |
National Institute for Agricultural and Food Research and Technology (INIA) | 43.6% | € 75.4 | $88.71 |
$ in Millions USD | Period | Ended | Sales | Chg. | Op. Prof. | Chg. | Net Prof. | Chg. |
---|---|---|---|---|---|---|---|---|
Datacolor* | FYE | 30-Sep | $61.00 | -22.6% | $0.30 | -94.6% | $41.60 | -5.9% |
HTG Molecular Diagnostics | Q3 | 30-Sep | $1,777.10 | -67.1% | -$5,171.53 | -11.9% | -$5,411.79 | -14.2% |
IDEX (Health & Sci Tech.) | Q3 | 30-Sep | $49.91 | 24.3% | $50.89 | -7.0% | NA | NA |
Kewaunee Scientific** | Q2 | 30-Sep | $39.00 | -1.8% | -$0.01 | 71.8% | -$0.17 | 92.4% |
MTS Systems* | Q4 | 30-Sep | $215.06 | -4.0% | -$283.26 | NM | -$280.68 | NM |
MTS Systems (Test & Simulation)* | Q4 | 30-Sep | $128.00 | -4.5% | -$96.35 | NM | NA | NA |
MTS Systems* | FYE | 30-Sep | $726.03 | -7.2% | -$247.49 | NM | -$272.05 | NM |
MTS Systems (Test & Simulation)* | FYE | 30-Sep | $490.63 | -12.2% | -$90.46 | NM | NA | NA |
Nanalysis Scientific | Q3 | 30-Sep | $1.70 | 3.6% | .-434 | NM | -$1.10 | -268.8% |
Pressure Biosciences | Q3 | 30-Sep | $533.86 | 6.5% | -$818.76 | 23.4% | -$3,675.72 | NA |
Other Currencies (in Millions) |
|
|
|
|
|
|
|
|
Diploma* | FYE | 30-Sep | £538.40 | -1.2% | £87.10 | -10.4% | £49.80 | -20.2% |
Eurotech | Q3 | 30-Sep | € 16.38 | -38.5% | € 0.69 | -84.0% | € 0.10 | -96.9% |
GL Sciences** | Q2 | 30-Sep | ¥13,210.00 | 12.5% | ¥1,859.00 | 49.7% | ¥1,026.00 | -99.8% |